Rocuronium Bromide
- Product NDC
- 43066-013
- 11-digit product format
- 430660013
- Labeler code
- 43066
- Product ID
- 43066-013_9e0317de-2d78-4fd8-8926-4c7b476f3ed4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rocuronium Bromide
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Baxter Healthcare Corporation
- Application
- ANDA091115
- Marketing category
- ANDA
- Marketing start
- 2019-07-15
- Substance
- ROCURONIUM BROMIDE
- Active strength
- 100 mg/10mL
- Pharmacologic classes
- Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rocuronium Bromide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ROCURONIUM BROMIDE | 100 mg/10mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | I65MW4OFHZ |
| Rxcui | 1234995 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 43066-013-10 | Rocuronium Bromide | 10 in 1 CARTON | INJECTION | 10 | | 7 |
| 43066-013-10 | Rocuronium Bromide | 10 mL in 1 VIAL | INJECTION | 10 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43066-013 | ROCURONIUM BROMIDE INJECTION [BAXTER HEALTHCARE CORPORATION] | 6 | Current NDC, Legacy NDC, 2 package rows | 20241017_31e15c3f-aefa-4379-b684-7707744fe40d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43066-013-10 | 43066001310 | 10 VIAL in 1 CARTON (43066-013-10) / 10 mL in 1 VIAL | 10 vial | 2019-07-15 | 0000-00-00 | No | No | Current |